We are gratified to receive this latest patent for our novel approach to cleanrooms.
COLLEGE STATION, Texas (PRWEB)
January 30, 2020
G-CON Manufacturing, the leader in prefabricated cleanrooms, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,533,758 for “Modular Parts that Supply Utilities to Cleanroom, Isolation or Containment Cubicles, Pods, or Modules,” to G-CON Manufacturing, Inc. The patent concerns G-CON’s invention of a removable portable units for providing utilities to cleanrooms for manufacturing pharmaceuticals or products that require high levels of cleanliness during manufacture.
The issuance of this patent adds to G-CON’s impressive patent estate for its novel turnkey approach of delivering prefabricated cleanrooms, called PODs. G-CON was founded on this proprietary platform, transforming the way that cleanrooms are designed and built. G-CON’s POD allows for more predictable results for its clients in terms of costs, schedule and quality.
“We are gratified to receive this latest patent for our novel approach to cleanrooms,” stated Sidney Backstrom, Vice President of Business Management for G-CON. “When we began as a company in 2009, modular pre-fabricated cleanrooms were thought of as a novel idea. Today, with a large patent estate and many successful installations and operating facilities, we have seen a sea change in our acceptance in the industry and look forward to the positive effect our approach will have in getting more needed therapies to patients.”
About G-CON Manufacturing
G-CON Manufacturing designs, builds and installs prefabricated G-CON POD® cleanrooms. G-CON’s POD portfolio provides cleanrooms in several dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD® cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com.
Share article on social media or email: